An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone online who’s been using Mounjaro (a diabetes and weight-loss medication) for almost three years posted that they’ve dropped from about 280 pounds to about 198–200 pounds. That’s more than the often-cited “average” of 20% weight loss, but they’ve been stuck at this weight for around six months. Their doctor says they’ve already hit the typical results and suggested surgery or diet/exercise to lose more. The poster says they’ve already been trying those things and is asking if others have tips or similar experiences. Mounjaro is the brand name for tirzepatide, a man-made drug that acts like certain gut hormones. Those hormones normally help control appetite and blood sugar. In simple terms: the drug tricks the body into feeling less hungry and helps stabilize blood sugar, so many people eat less and lose weight. It’s given by injection and was developed for diabetes but has become popular for weight loss, too. It’s not a magic pill — it helps some people a lot, others less, and the results can vary over time. What this post shows is a single-person, real-world experience, not a controlled clinical trial. Clinical studies of tirzepatide included hundreds to thousands of people and reported average weight loss numbers (that “20%” is a rough benchmark from some trial averages). But averages hide a lot of variety: some participants lost more than average and some less. Real patients often see an early period of steady loss followed by a plateau, where weight stops changing for months. That plateau can happen even after large overall losses. The post doesn’t offer new research — it’s a snapshot of one person’s long-term journey and frustration. Why this matters is practical: many people using drugs like Mounjaro want to know what long-term results look like and how to handle plateaus. If you’re thinking about the medication, this highlights that initial big losses can slow or stop, and that hitting a personal goal may not be automatic after a certain percentage. It also shows that medical advice can vary; some doctors may suggest surgery for additional weight loss, while others will keep recommending diet, exercise, or continuing medication. People deciding on next steps should consider how much more weight they want to lose, how the medication has affected their health overall, and whether other options make sense. Caveats: this is an anecdote, not proof of what will happen to anyone else. Tirzepatide can cause side effects like nausea, diarrhea, or changes in digestion, and there are longer-term unknowns for some people. Stopping the drug often leads to some weight regain unless other habits or treatments are in place. Bariatric (weight-loss) surgery is a major step with its own risks and benefits and isn’t the only route. Anyone thinking about changing medications, adding surgery, or making big lifestyle shifts should talk to a clinician who knows their full medical history. Bottom line: Mounjaro can produce big weight losses for some people, but plateaus are common and deciding what to do next is a personal medical choice, not a one-size-fits-all answer.
Source: r/Mounjaro